Lilly's weight loss drug cuts diabetes risk by 94% in three-year trial, company says

Health

Lilly's Weight Loss Drug Cuts Diabetes Risk By 94% In Three-Year Trial, Company Says

By NBC News

Eli Lilly’s weight loss drug cut the risk of developing Type 2 diabetes by 94% in prediabetic adults who were overweight or obese after three years of weekly injections, the company disclosed in a statement on Tuesday. The Indianapolis, Indiana-based ...Read more

Related Posts

Eli Lilly weight loss drug cuts risk of developing diabetes in trial

Eli Lilly weight loss drug cuts risk of developing diabetes in trial

Aug 20, 2024
Ozempic maker defends high U.S. price: It’s ‘helping’ reduce the cost of obesity

Ozempic maker defends high U.S. price: It’s ‘helping’ reduce the cost of obesity

Aug 25, 2024
Artificial sweetener erythritol could elevate heart disease risk, preliminary research suggests

Artificial sweetener erythritol could elevate heart disease risk, preliminary research suggests

Aug 09, 2024
'1,000-lb Sisters' star arrested at Tennessee zoo on drug possession, child endangerment charges

'1,000-lb Sisters' star arrested at Tennessee zoo on drug possession, child endangerment charges

Sep 03, 2024
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.